Browse News by Year:
News Highlights:
Mersana Therapeutics -- $21M Series B Co-led by Fidelity Biosciences
November 9, 2005 - Mersana, a privately-held cancer therapeutics company announced today that it has completed an oversubscribed $21 million financing. Fidelity Biosciences and ProQuest Investments led the round, with Rho Ventures and the company's previous investors participating, including... View Full Article
Envivo Appoints Kees Been As Chief Executive Officer
June 27, 2005 - EnVivo Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on developing drugs for neurodegenerative diseases, announced today the appointment of Kees Been as Chief Executive Officer. View Full Article
1 Main Street, 13th Floor
Cambridge, MA 02142
Tel: (617) 231-2400
Fax: (617) 231-2425
Cambridge, MA 02142
Tel: (617) 231-2400
Fax: (617) 231-2425
Mailing Address
Fidelity Biosciences
82 Devonshire Street, EPC13A
Boston, MA 02109-3614
E-Mail: FidelityBiosciences@fmr.com
82 Devonshire Street, EPC13A
Boston, MA 02109-3614
E-Mail: FidelityBiosciences@fmr.com
© 2010 Fidelity Biosciences. All rights reserved.